The Effect of Reducing Ejaculation Abstinence Time on Assisted Reproductive Technology Outcomes: a Prospective Randomized Controlled Study
Shorten abstinence time
Treatment Study
Summary
Study start date: May 1, 2024
Actual date on which the first participant was enrolled.This study is focusing on understanding if changing the time men abstain from ejaculation before a fertility treatment can make the process more successful. The research specifically looks at assisted reproductive technology, which includes procedures like in vitro fertilization (IVF). The usual recommendation for men is to abstain from ejaculation for 2-7 days, but this study is testing if a shorter period of just 48 hours could be more beneficial. This research is important as it could provide clearer guidelines for men undergoing fertility treatments, potentially improving the chances of conception for couples facing fertility issues. Participants in this study are divided into two groups. One group will abstain from ejaculation for 48 hours before the egg retrieval process, while the other group will follow the traditional 4-7 days of abstinence. The study will follow the results of their IVF treatments to compare the outcomes between the two groups. The aim is to see if the shorter abstinence period results in better fertility treatment outcomes. This involves carefully tracking the success of the IVF procedures to determine which method is more effective.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.500 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 20 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
the first hospital of Jilin University
Changchun, ChinaOpen the first hospital of Jilin University in Google Maps